BNBoris S. Negrutskii

Boris S. Negrutskii

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Boris S. Negrutskii has a total of 167 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Targeted lysine‐to‐arginine substitutions at methylation sites in eEF1A1 differentially modulate protein interactions and translation

    by Larysa V. Porubleva, Alexey Rayevsky, Agata Malinowska, Bianka Świderska, Oleksandra Novosylna, Oleksandr Tsuvariev, Magda Bakun, Denys Kolesnyk, Michal Dadlez, Boris Negrutskii

    Lysine methylation has emerged as an important regulatory mechanism for the human translation elongation factor eEF1A, which is modified at five distinct lysine residues; however, the functional consequences of these modifications for translation remain largely unclear. By combining in vitro and cellular assays with targeted mutagenesis of the major methylation sites, we show that substitution of methylatable Lys79 with arginine enhances the interaction between eEF1A1 and its guanine nucleotide exchange complex, eEF1B, whereas the Lys36Arg mutation reduces both global translation and translation fidelity in human cells. Molecular dynamics simulations indicate that trimethylation of Lys79 partially weakens the eEF1A1‐eEF1Bα interaction, an effect that can be counterbalanced by trimethylation of Lys318. These simulations also explain the previously reported absence of such inhibition in the eEF1A2 paralog. Mass spectrometry further reveals multiple nontranslational partners that preferentially associate with methylated or mutant eEF1A1 and confirms complete trimethylation of Lys36, Lys79, and Lys318 in differentiated tissue. Together, these findings highlight lysine methylation as an important modulator of eEF1A1, shaping its functions in translation and beyond.

  • Open Access

    Dynamics and structural features of the eEF1A1 and eEF1A2 paralogs

    by Oleksandra Novosylna, Vyacheslav Shalak, Katarzyna Dąbrowska, Ilias Patmanidis, Dmytro Lozhko, Tetiana Bondarchuk, Birgit Schiøtt, Jan S Pedersen, Charlotte R Knudsen, Poul Nissen, et al.

    The translation elongation factors eEF1A1 and eEF1A2 share 97% sequence similarity and perform similar roles in translation but exhibit mutually exclusive expression patterns in human tissues. Despite their high homology, they are linked to different diseases, likely due to paralog-specific interactions with distinct protein partners. The underlying reasons for these differences remain unclear. Here, using a combination of HDX-MS, MD, and SAXS approaches, we demonstrate that eEF1A1 and eEF1A2 exhibit distinct structural dynamics, leading to different structural organizations. eEF1A2 is a compact, stably folded protein, whereas eEF1A1 adopts multiple conformational states, including the opening and closing of the conformational space between domains D1 and D3, as well as significant internal and external dynamics of domain D2. These dynamics facilitate protein dimerization in eEF1A1, contrasting with eEF1A2, which apparently remains monomeric in solution, challenging previous X-ray crystallography findings. These data provide molecular insight into the functional differences between the highly homologous translation factors eEF1A1 and eEF1A2, potentially explaining their paralog-specific nontranslational roles and distinct contributions to human diseases.


  • Open Access

    Берегиня української науки

    by Михайло Арсентійович Тукало, Любов Леонідівна Лукаш, Борис Сергійович Негруцький, Тетяна Анатоліївна Сергеєва

    15 жовтня 2025 р. святкує своє 85-річчя непересічна особистість, всесвітньо відомий вчений у галузі молекулярної біології та біосенсорики, лауреат Державної премії України в галузі науки і техніки (1986), заслужений діяч науки і техніки України (1998), повний кавалер ордена княгині Ольги (2008, 2015, 2021), лауреат Золотої медалі імені В.І. Вернадського НАН України (2015), премії імені О.В. Палладіна НАН України (1979), директор Інституту молекулярної біології і генетики НАН України (2003—2019), доктор біологічних наук (1976), професор (1986), академік НАН України (1992) Ганна Валентинівна Єльська. Як цитувати: Тукало М.А., Лукаш Л.Л., Негруцький Б.С., Сергеєва Т.А. Берегиня української науки. До 85-річчя академіка НАН України Г.В. Єльської. Вісник НАН України. 2025. № 10. С. 90—96. https://doi.org/10.15407/visn2025.10.090

  • Understanding functions of eEF1 translation elongation factors beyond translation. A proteomic approach

    by Boris S Negrutskii, Larysa V Porubleva, Agata Malinowska, Oleksandra V Novosylna, Michal Dadlez, Charlotte R Knudsen


  • Open Access

    The eEF1 family of mammalian translation elongation factors

    by B.S. Negrutskii, V.F. Shalak, O.V. Novosylna, L.V. Porubleva, D.M. Lozhko, A.V. El'SKaya


  • Open Access

    Mass-spectrometric and bioinformatic analysis of eEF1Bγ interactome in the cytoplasmic fraction of A549 cells

    by L. M. Kapustian, I. L. Lysetsky, T. V. Bondarchuk, O. V. Novosylna, B. S. Negrutskii

    To study protein networks containing the translation elongation factor eEF1B gamma (eEF1Bγ) in lung carcinoma cells. Methods. The protein partners of eEF1Bγ in the cytoplasmic fraction of human lung adenocarcinoma A549 cells were identified by co-immunoprecipitation (co-IP) followed by subsequent liquid chromatography-tandem mass spectrometry (LC-MS/MS). The protein interaction network for eEF1Bγ was determined by a Cytoscape 3.2.0 program using a MCODE plugin. Results. 222 high-scored proteins interacting with eEF1Bγ in the cytoplasm of A549 cells have been identified. Possible functional networks involving these protein-protein interactions were predicted using bioinformatic approaches. Conclusions. Five protein networks were identified as possible targets of eEF1Bγ in lung cancer cells. Apart from translation, eEF1Bγ was shown to be potentially involved in cell cycle regulation, nucleosome remodeling, transcription, mRNA splicing and processing, and oxidative stress response.


  • mRNA‐Independent way to regulate translation elongation rate in eukaryotic cells

    by Boris Negrutskii, Dmytro Vlasenko, Marc Mirande, Pavlo Futernyk, Anna El'Skaya

    The question of what governs the translation elongation rate in eukaryotes has not yet been completely answered. Earlier, different availability of different tRNAs was considered as a main factor involved, however, recent data revealed that the elongation rate does not always depend on tRNA availability. Here, we offer another, codon‐independent approach to explain specific tRNA‐dependence of the elongation rate in eukaryotes. We hypothesize that the exit rate of eukaryotic translation elongation factor 1A (eEF1A)*GDP from the 80S ribosome depends on the protein affinity to specific aminoacyl‐tRNA remaining on the ribosome after GTP hydrolysis. Subsequently, a slower dissociation of eEF1A*GDP from certain aminoacyl‐tRNAs in the ribosome can negatively influence the ribosomal elongation rate in a tRNA‐dependent and mRNA‐independent way. The specific tRNA‐dependent departure rate of eEF1A*GDP from the ribosome is suggested to be a novel factor contributing to the overall translation elongation control in eukaryotic cells. © 2018 IUBMB Life, 70(3):192–196, 2018


  • Comparison of the ability of mammalian eEF1A1 and its oncogenic variant eEF1A2 to interact with actin and calmodulin

    by Oleksandra Novosylna, Annette Doyle, Dmytro Vlasenko, Mark Murphy, Boris Negrutskii, Anna El’skaya

    The question as to why a protein exerts oncogenic properties is answered mainly by well-established ideas that these proteins interfere with cellular signaling pathways. However, the knowledge about structural and functional peculiarities of the oncoproteins causing these effects is far from comprehensive. The 97.5% homologous tissue-specific A1 and A2 isoforms of mammalian translation elongation factor eEF1A represent an interesting model to study a difference between protein variants of a family that differ in oncogenic potential. We propose that the different oncogenic impact of A1 and A2 might be explained by differences in their ability to communicate with their respective cellular partners. Here we probed this hypothesis by studying the interaction of eEF1A with two known partners – calmodulin and actin. Indeed, an inability of the A2 isoform to interact with calmodulin is shown, while calmodulin is capable of binding A1 and interferes with its tRNA-binding and actin-bundling activitiesin vitro. Both A1 and A2 variants revealed actin-bundling activity; however, the form of bundles formed in the presence of A1 or A2 was distinctly different. Thus, a potential inability of A2 to be controlled by Ca2+-mediated regulatory systems is revealed.


  • A non‐catalytic N‐terminal domain negatively influences the nucleotide exchange activity of translation elongation factor 1Bα

    by Tetiana V. Trosiuk, Vyacheslav F. Shalak, Roman H. Szczepanowski, Boris S. Negrutskii, Anna V. El'SKaya

    Eukaryotic translation elongation factor 1Bα (eEF1Bα) is a functional homolog of the bacterial factor EF‐Ts, and is a component of the macromolecular eEF1B complex. eEF1Bα functions as a catalyst of guanine nucleotide exchange on translation elongation factor 1A (eEF1A). The C‐terminal domain of eEF1Bα is necessary and sufficient for its catalytic activity, whereas the N‐terminal domain interacts with eukaryotic translation elongation factor 1Bγ (eEF1Bγ) to form a tight complex. However, eEF1Bγ has been shown to enhance the catalytic activity of eEF1Bα attributed to the C‐terminal domain of eEF1Bα. This suggests that the N‐terminal domain of eEF1Bα may in some way influence the guanine nucleotide exchange process. We have shown that full‐length recombinant eEF1Bα and its truncated forms are non‐globular proteins with elongated shapes. Truncation of the N‐terminal domain of eEF1Bα, which is dispensable for catalytic activity, resulted in acceleration of the rate of guanine nucleotide exchange on eEF1A compared to full‐length eEF1Bα. A similar effect on the catalytic activity of eEF1Bα was observed after its interaction with eEF1Bγ. We suggest that the non‐catalytic N‐terminal domain of eEF1Bα may interfere with eEF1A binding to the C‐terminal catalytic domain, resulting in a decrease in the overall rate of the guanine nucleotide exchange reaction. Formation of a tight complex between the eEF1Bγ and eEF1Bα N‐terminal domains abolishes this inhibitory effect.